BioCentury
ARTICLE | Clinical News

EntreMed reports Phase II breast cancer data

September 11, 2007 1:36 AM UTC

ENMD presented interim Phase II data from 35 evaluable metastatic breast cancer patients that showed MKC-1 produced one complete response, two partial responses and three cases of stable disease lasti...